Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.0%

13 terminated/withdrawn out of 187 trials

Success Rate

86.7%

+0.2% vs industry average

Late-Stage Pipeline

13%

24 trials in Phase 3/4

Results Transparency

12%

10 of 85 completed trials have results

Key Signals

31 recruiting10 with results10 terminated

Enrollment Performance

Analytics

N/A
91(61.9%)
Phase 2
21(14.3%)
Phase 4
14(9.5%)
Phase 3
10(6.8%)
Phase 1
9(6.1%)
Early Phase 1
2(1.4%)
147Total
N/A(91)
Phase 2(21)
Phase 4(14)
Phase 3(10)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (187)

Showing 20 of 187 trials
NCT07094048Phase 4Recruiting

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

Role: lead

NCT05592938Not ApplicableRecruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Role: collaborator

NCT04754061Phase 1Active Not Recruiting

PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)

Role: collaborator

NCT06843148Not ApplicableRecruiting

Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.

Role: collaborator

NCT06884540Not ApplicableActive Not Recruiting

Optimizing Patient-centred Outcomes Using Opioid Minimization Strategies: The OPUS Anesthesia Pilot Trial

Role: lead

NCT07483658Not ApplicableRecruiting

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

Role: lead

NCT07668661Not ApplicableNot Yet Recruiting

OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders

Role: lead

NCT05597358Not ApplicableCompleted

Efficacy of High Intensity Laser for Provoked Vestibulodynia

Role: collaborator

NCT07534345Not ApplicableRecruiting

Efficacy of Dry Needling in Reducing Pain During Sexual Intercourse

Role: collaborator

NCT07067827Recruiting

Self-questionnaire in Osteoporosis

Role: lead

NCT03363217Phase 2Active Not Recruiting

Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.

Role: collaborator

NCT04670016Completed

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

Role: collaborator

NCT07525856Not ApplicableNot Yet Recruiting

Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis

Role: lead

NCT06817694Not ApplicableRecruiting

Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

Role: lead

NCT05402930Not ApplicableCompleted

Angiomammography and Neoadjuvant Chemotherapy

Role: lead

NCT05390229Completed

Screening Contrast-enhanced Mammography

Role: lead

NCT06276257Not ApplicableRecruiting

Paravertebral Block for Mastectomy With Immediate Reconstruction

Role: lead

NCT04171661Early Phase 1Active Not Recruiting

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

Role: lead

NCT04862260Early Phase 1Active Not Recruiting

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Role: lead

NCT07193134Phase 1Recruiting

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

Role: lead